| |
Herceptin - Metastatic Breast Cancer treatment |
 | | Status Herceptin in combination with paclitaxel is indicated for treatment of patients with metastatic breast cancer whose tumors overexpress the HER2 protein and who have not received chemotherapy for their metastatic disease. |
 | | Herceptin as a single agent is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress the HER2 protein and who have received one or more chemotherapy regimens for their metastatic disease. |
 | | Herceptin infusion should be interrupted for patients experiencing dyspnea or clinically significant hypotension. |
| www.gene.com /gene/products/information/oncology/herceptin/index.jsp (0 words) |